Reverse Transcriptase Inhibitors: all 1,328 studies that test it
Page 5 of 14. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.
- Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSPCompletedNCT05108935Not applicable
- Stop Hep B @ BirthStatus unknownNCT04998838Not applicable
- The Role of Home Packs of HIV PEPSE in High Risk IndividualsCompletedNCT04965662Phase 4
- Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected IndividualsCompletedNCT04904406Phase 4
- IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, KenyaCompletedNCT04898699Early Phase 1
- Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19CompletedNCT04890626Phase 3
- A Study of JNJ-56136379 in Healthy ParticipantsWithdrawnNCT04853524Phase 1
- Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)Active, not recruitingNCT04826562Phase 4
- A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy PreventionActive, not recruitingNCT04778527Not applicable
- Inhibition of Reverse Transcription in Aicardi-Goutières SyndromeCompletedNCT04731103Phase 2
- Reducing Vertical Transmission of Hepatitis B in AfricaActive, not recruitingNCT04704024Phase 3
- Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged HomeCompletedNCT04685512Phase 2/3
- Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A InducerStatus unknownNCT04680091Phase 1
- Pharmacokinetics of Two Formulation of Tenofovir Disoproxil FumarateCompletedNCT04671563Phase 4
- PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in KenyaCompletedNCT04666792Phase 4
- A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate AgentsCompletedNCT04661397Phase 1
- Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure ProphylaxisActive, not recruitingNCT04616963Phase 4
- Efavirenz 400mg in Treatment-naïve Chinese HIV-infected PatientsCompletedNCT04596488Not applicable
- Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender MenActive, not recruitingNCT04593680Not applicable
- HIV Pre-exposure Prophylaxis Implementation Study in South KoreaStatus unknownNCT04583267Not applicable
- Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping TestCompletedNCT04549467Phase 4
- Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNAStatus unknownNCT04539119Phase 3
- Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected PatientsStatus unknownNCT04513379Phase 3
- Bictegravir/FTC/TAF for the Treatment of Primary HIV InfectionStatus unknownNCT04483674Phase 2
- Evaluation of Drug Interaction Between HS-10234 and EmtriccitabineCompletedNCT04477096Phase 1
- Efficacy of Efavirenz 400mg vs. 600mg Combined With Lamivudine and Tenofovir in Treatment Naive HIV InfectionStatus unknownNCT04463784Not applicable
- ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI ResistanceStatus unknownNCT04429152Phase 3
- TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)TerminatedNCT04405271Phase 3
- A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative ResectionStatus unknownNCT04392700Phase 3
- A Study in Healthy Male Subjects to Investigate the Effect of Famotidine and Efavirenz on the Way the Body Takes up, Distributes, and Gets Rid of Daridorexant.CompletedNCT04390334Phase 1
- Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)CompletedNCT04388904Phase 4
- Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in ColombiaCompletedNCT04359095Phase 2/3
- DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years OldActive, not recruitingNCT04337450Phase 2/3
- Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare PersonnelCompletedNCT04334928Phase 3
- Accelerated PrEP Access for Black MSM and TWWithdrawnNCT04329442Not applicable
- Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed AdultsStatus unknownNCT04311957Phase 4
- Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral DrugsCompletedNCT04302896Early Phase 1
- Biktarvy in Treatment-Naïve Late Presenters With HIV-1 InfectionCompletedNCT04296695Phase 4
- Safety and Efficacy of Etravirine in Friedreich Ataxia PatientsCompletedNCT04273165Phase 2
- Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIVTerminatedNCT04249037Phase 4
- Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV InfectionStatus unknownNCT04240509Phase 4
- A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat When Administered as a Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared to the Co-administration of the Separate AgentsTerminatedNCT04236453Phase 1
- A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult ParticipantsCompletedNCT04208373Phase 1
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
- Neurological Monitoring in Patients Switching From Dolutegravir Based Regimen to Bictegravir Based RegimenStatus unknownNCT04155554Phase 3
- Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisCompletedNCT04142749Phase 3
- Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Marginalized Populations Who Are Virologically SuppressedStatus unknownNCT04132674Phase 4
- Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.CompletedNCT04114890Phase 2
- A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEPCompletedNCT04066881Phase 2
- RPV+DRV/Cobi Dual Therapy in Subjects With HIV Controlled InfectionStatus unknownNCT04064632Phase 4
- RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative ResectionActive, not recruitingNCT04032860Phase 4
- ANRS 12372 MODERATO StudyCompletedNCT04022967Phase 3
- Nucleosides And Darunavir/Dolutegravir In AfricaStatus unknownNCT03988452Phase 3
- The CHAPS Trial: Combined HIV Adolescent PrEP and PreventionCompletedNCT03986970Phase 2
- Combination Antiretroviral Therapy (cART) for PBCCompletedNCT03954327Phase 2
- Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver FibrosisStatus unknownNCT03920605Not applicable
- BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) StudyStatus unknownNCT03916328Phase 4
- Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus InfectionCompletedNCT03903796Phase 3
- Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid DispersionsCompletedNCT03886766Not applicable
- Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive InterventionCompletedNCT03870438Phase 3
- Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEVStatus unknownNCT03869944Phase 2
- Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)WithdrawnNCT03834909Phase 1
- Drug-Drug Interaction Study of Vadadustat With Digoxin, Adefovir and FurosemideCompletedNCT03801759Phase 1
- Single Dose Truvada StudyCompletedNCT03719053Phase 1
- Efavirenz for Patients With Alzheimer's DiseaseCompletedNCT03706885Phase 1
- Body Composition Sub-study of the D2EFT TrialCompletedNCT03675815Phase 4
- Efficacy of Rilpivirine-based Regimens as Switch Therapy From Nevirapine-based Regimens in HIV-infected PatientsCompletedNCT03664440Not applicable
- Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - PK StudyCompletedNCT03652623Phase 1/2
- A Study in Healthy VolunteersCompletedNCT03596697Phase 1
- Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive ImplantStatus unknownNCT03589040Phase 2
- Darunavir and Rilpivirine Interactions With Levonorgestrel ImplantStatus unknownNCT03589027Phase 2
- Neurocognitive Function Improvement After Switching From Efavirenz to RilpivirineStatus unknownNCT03567304Phase 4
- A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) InfectionTerminatedNCT03563742Phase 3
- Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.Status unknownNCT03539224Phase 2
- Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1CompletedNCT03502005Phase 4
- Evaluate the Efficacy and Safety to Tenofovir Disoproxil in Chronic Hepatitis B PatientsCompletedNCT03485534Phase 4
- Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical TransmissionStatus unknownNCT03476083Phase 4
- The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After DiscontinuationCompletedNCT03468907Phase 4
- The Kampala Women's Bone StudyCompletedNCT03464266Phase 4
- Dual Obstructive Sleep Apnea TherapyStatus unknownNCT03435731Not applicable
- Same-Day Treatment With Genvoya vs. EFV/TDF/3TCWithdrawnNCT03405194Not applicable
- Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B InfectionActive, not recruitingNCT03343431Phase 3
- Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current RegimenTerminatedNCT03333083Phase 3
- Western Australian Pre-exposure Prophylaxis for HIV Implementation TrialCompletedNCT03327155Phase 3
- Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and TenofovirCompletedNCT03309566Phase 4
- Reverse Transcriptase Inhibitors in Aicardi Goutières SyndromeWithdrawnNCT03304717Phase 1/2
- Project EMPOWERING: Evidence-based PrEP for Justice-Involved Women and Their Risk NetworksCompletedNCT03293290Phase 1
- A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender WomenCompletedNCT03270969Phase 1
- Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological SuppressionCompletedNCT03251690Not applicable
- Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus AdefovirStatus unknownNCT03236584Phase 3
- Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating WomenCompletedNCT03227731Phase 2/3
- Implementation of PrEP to HIV in Brazilian Transgender WomenStatus unknownNCT03220152Phase 4
- Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD)CompletedNCT03216538Phase 1/2
- The Incidence of Postpartum Hepatitis in Pregnant Women With Chronic Hepatitis B Virus InfectionStatus unknownNCT03214302Not applicable
- RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TPCompletedNCT03186482Phase 1
- Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)TerminatedNCT03163277Phase 4
- 3Ps for Prevention Study (Perception, Partners, Pills)Status unknownNCT03142256Phase 4
- A Study to Investigate the Effect of Different Particle Sizes on the Single-dose Pharmacokinetics of Rilpivirine After Intramuscular Injection of a Long-acting Nanosuspension in Healthy ParticipantsCompletedNCT03127189Phase 1
- ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral TherapyCompletedNCT03122262Phase 3